AOD 9604 Dragon Peptides

What is AOD 9604 5 mg?

AOD 9604 is a synthetic peptide, a modified fragment of human growth hormone (HGH, amino acids 176–191), supplied as a 5 mg vial from Dragon Pharma. Originally developed as an anti-obesity drug, it's used in bodybuilding for its fat-burning properties without anabolic or insulin-related effects. Supplied as a lyophilized powder requiring reconstitution with bacteriostatic water, it has no hepatotoxicity, no aromatization, and minimal side effects when used responsibly.

Mechanism of Action AOD 9604

AOD 9604 stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat storage) by mimicking the fat-burning portion of HGH. It may upregulate beta-3 adrenergic receptors in adipose tissue, enhancing fat metabolism without increasing IGF-1 or affecting blood sugar. Users notice fat loss, particularly in stubborn areas, within weeks when paired with a calorie-deficit diet. Its half-life is not well-documented but requires daily injections for consistent effects. It avoids hormonal pathways, ensuring no endocrine disruption.

How It Works & Key Benefits

AOD 9604 excels for bodybuilders in cutting cycles, requiring a calorie-deficit, high-protein diet and exercise to maximize fat loss while preserving muscle.

• Promotes fat loss, especially in stubborn areas.
• Prevents fat storage for leaner body composition.
• Preserves lean muscle mass during calorie deficits.
• Boosts metabolism without hormonal side effects.
• Supports energy stability for training endurance.
• Stacks well with other fat-loss agents.

Who It's For & Product Specifications

Best for bodybuilders and fitness enthusiasts seeking fat loss in cutting cycles; suitable for men and women. Not recommended for those with peptide allergies or without injection knowledge.

Substance	Anti-Obesity Drug-9604 (AOD 9604)
Concentration	5 mg/vial
Form	Lyophilized powder (injectable)
Pack Size	1 vial
Half-life	Not well-documented; daily dosing advised
Aromatization/Hepatic	Non-aromatizing / Non-hepatic
Primary Use	Fat loss, body recomposition
Manufacturer	Dragon Pharma
Brand	AOD9604

How Much AOD 9604 5 mg for Bodybuilding?

For bodybuilding, 300-500 mcg/day is typical, split into 1-2 subcutaneous injections (e.g., morning or pre-workout). Beginners start at 300 mcg/day to assess tolerance, while advanced users may use up to 500 mcg/day, guided by professional oversight. Consult professionals for personalized dosing.

How to Use

1. Dosage: 300-500 mcg/day, split into 1-2 subcutaneous injections; start at 300 mcg to assess tolerance.
2. Frequency: Daily, preferably morning or pre-workout for optimal fat-burning effects.
3. Cycle length: 4-8 weeks for fat loss, with breaks to assess progress.
4. Preparation/Monitoring tips: Reconstitute with 2 ml bacteriostatic water for 2.5 mg/ml; use insulin syringes; store refrigerated at 2-8°C; monitor body composition; maintain a calorie-deficit, high-protein diet (1.5-2g/kg body weight).
5. Results timeline: Fat loss in 2-4 weeks with consistent use, diet, and exercise.
6. PCT timing: Not required as AOD 9604 doesn't suppress hormones; align with steroid stack's PCT if combined (e.g., 3-4 days post-short ester).

Popular Stacks

Clenbuterol: Enhances thermogenesis for synergistic fat loss.

Anavar: Preserves lean muscle during cutting.

CJC-1295: Boosts GH release for additional fat metabolism.

Cycle Support: Supports metabolic health during protocols.

Comparisons & Alternatives

AOD 9604 vs Semaglutide: AOD 9604 targets fat metabolism without appetite suppression; Semaglutide is a GLP-1 agonist with stronger appetite control.

AOD 9604 vs Clenbuterol: AOD 9604 is non-stimulant with targeted fat loss; Clenbuterol provides rapid thermogenesis with stimulant risks.

AOD 9604 vs HGH: AOD 9604 focuses on fat loss without anabolic effects; HGH offers broader muscle-building and recovery benefits.

Side Effects & Risk Management

• Dermatologic: Mild injection site redness—use sterile technique, rotate sites.
• Systemic: Rare headaches or fatigue—lower dose if occurs.
• Endocrine: None; no hormonal suppression or IGF-1 impact.
• Cardiometabolic: None; no significant BP or lipid effects.
• Hepatic: None; no liver toxicity.

Review administration with a professional where lawful to ensure authenticity and safe dosing. AOD 9604 is not FDA-approved for bodybuilding and is sold for research purposes only.

Post-Cycle Therapy (PCT)

AOD 9604 requires no PCT as it doesn't suppress testosterone or HPTA; align with steroid stack's PCT if combined (e.g., 3-4 days post-short ester). Use tamoxifen or clomiphene for 4 weeks if needed, guided by bloodwork.